X4 Pharmaceuticals, Inc.
USD4.23
+0.21 (+5.22%)
CEO
Adam R. Craig
IPO Date
2017-11-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.06
Prev. Close
$4.02
Day Low
$4.00
Day High
$4.25
52W Low
$1.35
52W High
$4.83
Market Cap
$0.40B
Volume
0.58M
| -3.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -198.0% | -68.7% | 1.14 | 5.34 | -1.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -126.8% | -60.3% | 0.52 | 5.76 | -0.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -137.7% | -75.7% | 0.62 | 6.27 | -0.7 |
| 31 Dec 2020 | FY | 59.0% | -2071.0% | -85.3% | -50.6% | 0.53 | 6.97 | -2.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -40.9% | -32.9% | 0.18 | 13.68 | -2.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 285.0% | -334.7% | -0.84 | 1.18 | -0.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -57.7% | -41.7% | 0.21 | 7.45 | -0.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 137.4% | -302.1% | -0.91 | 0.47 | -1.5 |
| -4.6 |
| 30 Sept 2025 | Q3 | 78.8% | -1689.2% | -48.4% | -18.2% | 1.26 | 5.65 | -1.2 |
| 30 Jun 2025 | Q2 | 75.0% | -1304.7% | -648.2% | -24.5% | 19.65 | 3.19 | -0.1 |
| 31 Mar 2025 | Q1 | 82.6% | 1.0% | 1.2% | 0.2% | 3.40 | 3.70 | 43.0 |
| 31 Dec 2024 | Q4 | 78.9% | -2776.9% | -179.8% | -27.2% | 3.53 | 3.41 | -0.9 |
| 30 Sept 2024 | Q3 | 45.2% | -6552.9% | -61.5% | -20.6% | 1.31 | 4.89 | -0.9 |
| 30 Jun 2024 | Q2 | 17.9% | 16133.7% | 96.2% | 43.1% | 0.83 | 6.07 | 0.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -4996.7% | -46.1% | 56.25 | 3.71 | -1.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -37.4% | -13.0% | 1.14 | 5.34 | -2.2 |